Researchers survey Real-World experiences of injectable Weight-Loss drug
NCT ID NCT07154238
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 22 times
Summary
This study gathers information from adults who have been prescribed injectable semaglutide for weight management. Participants complete online surveys about their health, weight changes, and quality of life. The study does not provide any treatment or collect lab data. It aims to better understand the characteristics and experiences of people using this medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Bad Oeynhausen, 32545, Germany
Conditions
Explore the condition pages connected to this study.